Shanghai Guangsheng Biopharmaceutical Co., Ltd
Quick facts
Phase 3 pipeline
- Cisplatin for injection · Oncology
Cisplatin is a platinum-based chemotherapy agent that forms DNA crosslinks, preventing DNA replication and transcription in cancer cells.
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Shanghai Guangsheng Biopharmaceutical Co., Ltd portfolio CI brief
- Shanghai Guangsheng Biopharmaceutical Co., Ltd pipeline updates RSS
Frequently asked questions about Shanghai Guangsheng Biopharmaceutical Co., Ltd
What is Shanghai Guangsheng Biopharmaceutical Co., Ltd's pipeline?
Shanghai Guangsheng Biopharmaceutical Co., Ltd has 1 drugs in Phase 3, 1 in Phase 2, 0 in Phase 1. Late-stage candidates include Cisplatin for injection.
Related
- Sector hub: All tracked pharma companies